He L - Search Results

1

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.

Yin L, Liu Y, Peng Y, Peng Y, Yu X, Gao Y, Yuan B, Zhu Q, Cao T, He L, Gong Z, Sun L, Fan X, Li X. Yin L, et al. Among authors: he l. J Exp Clin Cancer Res. 2018 Jul 16;37(1):153. doi: 10.1186/s13046-018-0810-7. J Exp Clin Cancer Res. 2018. PMID: 30012171 Free PMC article.

2

Anacardic acid sensitizes prostate cancer cells to radiation therapy by regulating H2AX expression.

Yao K, Jiang X, He L, Tang Y, Yin G, Zeng Q, Jiang Z, Tan J. Yao K, et al. Among authors: he l. Int J Clin Exp Pathol. 2015 Dec 1;8(12):15926-32. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26884865 Free PMC article.

3

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.

Liu Y, Liu Y, Yuan B, Yin L, Peng Y, Yu X, Zhou W, Gong Z, Liu J, He L, Li X. Liu Y, et al. Among authors: he l. Oncotarget. 2017 Mar 7;8(10):17027-17037. doi: 10.18632/oncotarget.15224. Oncotarget. 2017. PMID: 28199985 Free PMC article.

4

A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.

Liu T, Peng Y, Li X, Liu L, Liu F, He L. Liu T, et al. Among authors: he l. Bioorg Med Chem. 2017 Oct 15;25(20):5461-5467. doi: 10.1016/j.bmc.2017.08.003. Epub 2017 Aug 4. Bioorg Med Chem. 2017. PMID: 28818459

5

Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade.

Wang N, Liu JY, Li X, Deng MH, Long Z, Tang J, Yao K, Zhang YC, He LY. Wang N, et al. Asian J Androl. 2019 Jan 1;21(1):56-61. doi: 10.4103/aja.aja_50_18. Asian J Androl. 2019. PMID: 30027930 Free PMC article.

6

Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo.

Xia L, Kang D, Wan D, Chu C, Chen M, Zhang S, Li X, He L, Yan J, Liu T, Peng Y. Xia L, et al. Among authors: he l. ACS Omega. 2020 Jul 29;5(31):19844-19852. doi: 10.1021/acsomega.0c02832. eCollection 2020 Aug 11. ACS Omega. 2020. PMID: 32803080 Free PMC article.

7

Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells.

Yin L, Liu Y, Peng Y, Peng Y, Yu X, Gao Y, Yuan B, Zhu Q, Cao T, He L, Gong Z, Sun L, Fan X, Li X. Yin L, et al. Among authors: he l. J Exp Clin Cancer Res. 2022 Feb 22;41(1):72. doi: 10.1186/s13046-022-02290-9. J Exp Clin Cancer Res. 2022. PMID: 35193658 Free PMC article. No abstract available.

8

[Expression of Raf kinase inhibitor protein and E-cadherin in prostate cancer tissues].

Lu S, Zhong K, Zhu L, He L. Lu S, et al. Among authors: he l. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Sep;34(9):892-7. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19779262 Chinese.

9

[Vinculin and the androgen receptor in prostate cancer: expressions and correlations].

Zhu LY, Zhong KB, Lu SX, He LY. Zhu LY, et al. Zhonghua Nan Ke Xue. 2010 Sep;16(9):794-8. Zhonghua Nan Ke Xue. 2010. PMID: 21171262 Chinese.

10

[Transfection of iNOS suppresses the growth of androgen-independent prostate cancer DU145 cells].

Chen YF, Jiang XZ, He LY, Tang YX, Long Z. Chen YF, et al. Zhonghua Nan Ke Xue. 2012 Aug;18(8):697-702. Zhonghua Nan Ke Xue. 2012. PMID: 22934514 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,360 results

Search Page

Filters